InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Quinn Anthony G., Chief Executive Officer. Insider active across 2 companies, notably Generation Bio Co.. Aggregated, 6 disclosures have been published. Total volume traded: €517k. The latest transaction was disclosed on 16 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€171,11880,079 shares@ €2.136933.1% of flow
Common Stock
SEC:0001209191-22-019929:0·
Ideal exit: 11 Dec 2022 (T+270)
€65,17234,777 shares@ €1.87412.6% of flow
Common Stock
SEC:0001209191-22-018942:0·
Ideal exit: 6 Dec 2022 (T+270)
€140,58343,108 shares@ €3.2612100.0% of flow
Common Stock
SEC:0001209191-21-069350·
Ideal exit: 5 Sept 2022 (T+270)
€140,58343,108 shares@ €3.261227.2% of flow
Common Stock
SEC:0001209191-21-069350:0·
Ideal exit: 5 Sept 2022 (T+270)
072,837 shares0
Common Stock
SEC:0001415889-21-005028·
072,837 shares0
Common Stock
SEC:0001415889-21-005028:0·
6 of 6 declarations
About Quinn Anthony G.
Anthony G. Quinn is the President and CEO of Generation Bio Co. and Aeglea BioTherapeutics, Inc. He leads the operations and overall strategy of the companies, focusing on innovation in the biopharmaceutical sector.
